Epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers in Hubei Province, China
- PMID: 33203485
- PMCID: PMC7691647
- DOI: 10.1017/ice.2020.1321
Epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers in Hubei Province, China
Abstract
Objective: To evaluate the epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers (HCWs) in Hubei Province, China.
Design: Retrospective cohort study.
Setting: Hubei Provincial Center for Disease Control and Prevention.
Participants: The participants in this study are cases identified by epidemiological investigation in Hubei Province, as of February 27, 2020, and were followed until March 7, 2020. In total, 1,989 HCWs and 41,137 other occupational cases were included for analysis.
Methods: We used descriptive statistics to summarize patient characteristics.
Results: Of 1,989 laboratory-confirmed HCWs, 297 (14.93%) had severe or critical cases, 73 (3.67%) had asymptomatic infections, and 18 died of coronavirus disease 2019 (COVID-19). The case fatality rate was 0.9%. The proportion of severe or critical cases decreased from the beginning to the end of the outbreak (from 21.29% to 3.52%), and the proportion of asymptomatic cases increased from 0.0% to 47.18%. Nearly half of HCWs with confirmed COVID-19 reported no known contact with COVID-19 patients (969, 48.72%). Fever and cough were the most common symptoms at disease onset in both HCWs and other occupational cases; however, HCWs had higher rates of fatigue (30.90% vs 25.02%; P < .001) and myalgia (19.15% vs 13.43%; P < .001). Additionally, compared with other occupational groups, HCWs were associated with a lower risk of death after adjustment for potential confounders (odd ratio [OR], 0.50; 95% confidence interval [CI], 0.30-0.79).
Conclusions: Compared with COVID-19 cases in other occupational groups, HCWs with COVID-19 have half the risk of death, although they have been shown to have higher rates of fatigue and myalgia.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
Figures
Similar articles
-
Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China.JAMA Netw Open. 2020 May 1;3(5):e209666. doi: 10.1001/jamanetworkopen.2020.9666. JAMA Netw Open. 2020. PMID: 32437575 Free PMC article.
-
Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.Clin Microbiol Infect. 2020 Dec;26(12):1670-1675. doi: 10.1016/j.cmi.2020.08.038. Epub 2020 Sep 7. Clin Microbiol Infect. 2020. PMID: 32911080 Free PMC article.
-
The impact of government pandemic policies on the vulnerability of healthcare workers to SARS-CoV-2 infection and mortality in Jakarta Province, Indonesia.Ann Med. 2023;55(2):2293306. doi: 10.1080/07853890.2023.2293306. Epub 2024 Jan 11. Ann Med. 2023. PMID: 38206905 Free PMC article.
-
Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis.J Med Virol. 2022 Apr;94(4):1428-1441. doi: 10.1002/jmv.27457. Epub 2021 Nov 24. J Med Virol. 2022. PMID: 34783055 Free PMC article.
-
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.Am J Obstet Gynecol. 2020 May;222(5):415-426. doi: 10.1016/j.ajog.2020.02.017. Epub 2020 Feb 24. Am J Obstet Gynecol. 2020. PMID: 32105680 Free PMC article. Review.
Cited by
-
Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection.Clin Infect Dis. 2022 Aug 24;75(1):e257-e266. doi: 10.1093/cid/ciab717. Clin Infect Dis. 2022. PMID: 34411230 Free PMC article.
-
Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.Vaccine. 2022 Nov 28;40(50):7167-7169. doi: 10.1016/j.vaccine.2022.10.053. Epub 2022 Oct 26. Vaccine. 2022. PMID: 36344360 Free PMC article. No abstract available.
-
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19.Signal Transduct Target Ther. 2021 Aug 25;6(1):316. doi: 10.1038/s41392-021-00731-z. Signal Transduct Target Ther. 2021. PMID: 34433805 Free PMC article. Review.
-
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms.Brain Hemorrhages. 2023 Sep;4(3):154-173. doi: 10.1016/j.hest.2023.02.001. Brain Hemorrhages. 2023. PMID: 36789140 Free PMC article. Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Coronavirus disease (COVID-19) pandemic. World Health Organization website. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Published 2020. Accessed March 31, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous